![](https://assets-global.website-files.com/635931b47ccaceb761762f45/635931b47ccace69af762f5f_Stalicla%20REPO4EU%20award%20post.jpeg)
REPO4EU, is the Euro/Global Platform for Drug Repurposing from imprecise drug therapy to AI-powered precision medicine, has selected Stalicla as a partner & awarded them with 1.7 EUR M.
The award is yet another validation of Stalicla in-house neurodevelopmental disorder-specific precision medicine discovery platform (DEPI).
Congrats team!